Microarray evaluation of specific IgE to allergen components in elite athletes
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background: Allergic sensitization and diseases have been reported to have a very high and increasing prevalence in elite athletes. Over 80% of allergic athletes are poly‐sensitized. Objective: This study aims at evaluating the potential diagnostic added value of a microarray technology (Immuno CAP ISAC, P hadia AB [at present Thermo Fisher Scientific] U ppsala, Sweden which detects IgE antibodies to specific or cross‐reacting allergen components. Methods: Seventy‐two poly‐sensitized athletes according to skin prick test (SPT) with different allergic phenotypes (asthma n = 19; rhino‐conjunctivitis n = 20; food allergy and/or oral allergy syndrome n = 13; no clinical symptoms n = 20) and two different control populations (20 poly‐sensitized sedentary subjects with respiratory allergy and 20 healthy athletes with negative SPT) were studied for detecting specific IgE (sIgE) both to allergen extracts (I mmuno CAP s IgE) and to allergen components (I mmuno CAP ISAC). Results: Immuno CAP ISAC detected the presence of sIgE in 90% of poly‐sensitized athletes – in 96% with symptoms and in 75% without symptoms – and in 100% of allergic controls. The pattern of positivity towards the 103 components tested differed from subject to subject, even in those with the same sensitization to allergen extract SPT or sIgE. Based on the ISAC results, poly‐sensitized athletes were classified into the following prototypical patterns, differently represented in the clinical phenotypes studied (P = 0.03): (1) One single predominant specific allergen positivity; (2) sIgE to two or more non‐cross‐reacting allergens; (3) sIgE to cross‐reacting allergens; and (4) sIgE to components potentially responsible for severe allergic reactions. Conclusions: The Immuno CAP ISAC represents a useful additional tool for diagnosis and management of poly‐sensitized athletes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Helenius, I. J., Tikkanen, H. O., Sarna, S., & Haahtela, T. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70173-3 · Cited by 242
Molecular diagnosis in allergy
Sastre, J. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03585.x · Cited by 235 · cited 2×
“• Molecular markers of sensitizations potentially responsible for severe allergic reactions, particularly to foods (Ara h 1,2,3; Pru p 3; Cor a 8; omega-5 gliadin; lipid transfer proteins) (12, 13).”
Background
Cited by
Fungi: the neglected allergenic sources
Crameri, R., Garbani, M., Rhyner, C., & Huitema, C. (2014) · Allergy · doi:10.1111/all.12325 · Cited by 207
Konradsen, J. R., Nordlund, B., Onell, A., Borres, M. P., Grönlund, H., & Hedlin, G. (2014) · Pediatric Allergy and Immunology · doi:10.1111/pai.12198 · Cited by 109
Multiplex component‐based allergen microarray in recent clinical studies
Patelis, A., Borres, M. P., Kober, A., & Berthold, M. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12761 · Cited by 49
Westwood, M., Ramaekers, B., Lang, S., Armstrong, N., Noake, C., de Kock, S., Joore, M., Severens, J., & Kleijnen, J. (2016) · Health Technology Assessment · doi:10.3310/hta20670 · Cited by 49
Metadata
- Authors
- Bonini, M., Marcomini, L., Gramiccioni, C., Tranquilli, C., Melioli, G., Canonica, G. W., Bonini, S., & on behalf of the ISAC Study Group
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2012-10-04
- Volume
- 67
- Issue
- 12
- Pages
- 1557-1564
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W1993793310
- Cited by
- 26
- References
- 2
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Microarray evaluation of specific IgE to allergen components in elite athletes. https://app.cochat.ai/papers/10.1111/all.12029
- The paper
- Bonini, M., Marcomini, L., Gramiccioni, C., Tranquilli, C., Melioli, G., Canonica, G. W., Bonini, S., & on behalf of the ISAC Study Group. (2012). Microarray evaluation of specific IgE to allergen components in elite athletes. Allergy. https://doi.org/10.1111/all.12029
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.